The Happy Broadcast logo

Over seven million women suffer from breast cancer, making it one of the deadliest cancers across the globe.



A team of researchers at the University of Washington School of Medicine (UWSM) has been working on a breast cancer vaccine for over the last 20 years. In their recently published study, they finally revealed the results of the phase one human trials of their breast cancer vaccine.



The study is published in the journal JAMA Oncology.

During the phase one trials, the experimental breast cancer vaccine has proved to be safe and highly effective in preventing the growth of human epidermal growth receptor 2 (HER2) cancer tumor cells.

High levels of HER2 protein in the body are responsible for causing the most complex, aggressive, and rapidly spreading type of breast cancer in women. Therefore, the new vaccine might turn out to be a groundbreaking discovery in the field of modern medicine.



The researchers are now conducting phase two trials of their vaccine. If successful, it’d be one of the greatest miracles of medical science – fingers crossed!

Source: Interesting Engineering

https://interestingengineering.com/health/her2-breast-cancer-vaccine

Share